Sarah Burke, Andrew Krasley, Maria Winters Hepatitis C Virus (HCV): Serine Protease Inhibitors.
Antiviral Approaches Against HCV PEG-INF + Ribavirin Therapy. Host / Viral Factors Affecting Treatment Response. Adverse Effect of Therapy. Sofosbuvir.
Antiviral Approaches Against HCV
Hepatitis C virus
HEPATITIS C CO-INFECTION. Hepatitis C (HCV) = RNA VIRUS Worldwide prevalence of Approx 150million Able to survive outside the body for up to 3 weeks Ongoing.
